Search
for
Sort by
Research 61–90 of 1000+
- A Systematic Literature Review of Alopecia Areata in Children and Adolescents: Psychosocial Impact
- A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areata
- Components of Severity in Alopecia Areata
- Association Between Alopecia Areata and High‐Sensitivity Cardiac Troponin T as a Marker of Subclinical Myocardial Injury
- Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape
- High-Frequency Ultrasonography in Hair and Nail Disorders—How It May Be Helpful
- An Evaluation of Generic and Disease‐Specific Patient‐Reported Outcome Measures to Assess the Impact of Percentage of Scalp Hair Loss on Health‐Related Quality of Life in a European Population
- Role of trichoscopy in diagnosis of different hair and scalp disorders in pediatrics
- rwSALT: a regrowth-weighted SALT score providing direct pixel-level measurement rather than visual estimation
- Ứng dụng Trichoscope trong hỗ trợ chẩn đoán bệnh rụng tóc từng mảng và rụng tóc Androgen
- Scoring systems for pemphigus
- Intralesional Botulinum Toxin A Injection for Recalcitrant Alopecial Totalis and Alopecia Universalis: A Randomized, Double-Blind, Placebo-Controlled Trial
- Validity and Advantages of Three-Dimensional High-Frequency Ultrasound in Dermatological Evaluation
- Trichoscopy as an essential diagnostic technique for hair and scalp disorders in skin of color: A case-control study
- Trichoscopy
- Dermoscopic Assessment of Nail Alterations in Egyptian Patients with Alopecia Areata
- Assessment of Serum Level of Brain-Derived Neurotrophic Factor (BDNF) In Pediatric Alopecia Areata: A Case - Control Study
- ASSESSMENT OF SERUM LEVELS OF ANTIGLIADIN ANTIBODIES (IgG and IgA) IN PATIENTS WITH ALOPECIA AREATA AND THEIR RELATION TO SEVERITY OF THE DISEASE
- ASSESSMENT OF SERUM LEVELS OF ANTIGLIADIN ANTIBODIES (IGG AND IGA) IN PATIENTS WITH ALOPECIA AREATA AND THEIR RELATION TO SEVERITY OF THE DISEASE
- Assessment of a Bidirectional Association Between Major Depressive Disorder and Alopecia Areata
- Assessment of Thyroid Dysfunction and Cortisol Levels in Patients with Alopecia Areata
- Development and validation of the Brigham Eyelash Tool for Alopecia (BELA): A measure of eyelash alopecia areata
- Quality of life in patients with alopecia areata: a hospital‐based cross‐sectional study
- Sublingual tofacitinib for alopecia areata: a roll‐over pilot clinical trial and analysis of pharmacokinetics
- Tofacitinib for the treatment of severe alopecia areata and variants: A retrospective cohort study of 90 patients
- Quality-of-Life Assessment in Singaporean Children with Alopecia Areata
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study